Overview

A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation

Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate multiple doses of BLI801 Laxative for safety and efficacy versus placebo in adults experiencing non-idiopathic constipation.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Braintree Laboratories
Treatments:
Cathartics
Laxatives